Co-Authors
This is a "connection" page, showing publications co-authored by CHARLES LU and SERGEJ NAUMOVICH KONOPLEV.
Connection Strength
0.103
-
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther. 2022 Apr 01; 7(1):110.
Score: 0.052
-
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther. 2022 02 21; 7(1):51.
Score: 0.051